Find your path to Maziar
378 people in our graph share verified history with Maziar — schools, employers, funds. One of them is your warm intro.
Michael LintsunlockedMaziar: together at Harvard Business School (2012)
×10Maziar: together at Harvard Business School
Maziar: together at Novo Nordisk
About
Maziar Mike Doustdar is President and CEO of Novo Nordisk, a company focused on the treatment and prevention of serious chronic diseases, including obesity, overweight, and diabetes. In this role, he oversees the company's work on reducing the incidence of metabolic and cardiovascular diseases, supporting earlier diagnosis, and providing patient treatment.
Executive at Novo Nordisk
Intro paths
→
In turn, Maziar can intro founders to Novo Nordisk's investors below.
Novo Nordisk's investors · 2
Experience
- Novo NordiskPresident and CEOcurrent2025 — presentDenmark
- Novo NordiskExecutive Vice President (EVP), International Operations at Novo Nordisk2016 — 2025Zurich, Switzerland
- Novo NordiskExecutive Vice President (EVP), Emerging Markets2015 — 2016Zurich, Switzerland
- Novo NordiskSenior Vice President (SVP), Emerging Markets2013 — 2015Switzerland
- Novo NordiskRegional Corporate Vice President (CVP), Emerging Markets2012 — 2013Malaysia
- Novo NordiskRegional Vice President (VP), Emerging Markets2010 — 2012Turkey
- Novo NordiskGeneral Manager2007 — 2010Turkey
- Novo NordiskBusiness Operations Director2005 — 2007Switzerland
- Novo NordiskBusiness Information & Staffs Director2002 — 2005Switzerland
- Novo NordiskRegional IT Director2000 — 2002Greece
- Novo NordiskIT Manager1997 — 2000Austria
- Novo NordiskFinance Manager1995 — 1997Austria
- Novo NordiskFinance Assistant1993 — 1995Austria
- Novo NordiskOffice Clerk / Reception1992 — 1993Austria
- PhRMABoard Membercurrent2026 — present
- Orion CorporationMember of the Board2022 — 2026Espoo, Finland
Skills & more
Sales Effectiveness99Pharmaceutical Industry99Pharmaceutical Sales99Negotiation74Marketing Management99Diabetes99Process Optimization31Global Marketing80Change Management99Business Strategy99Cross-functional Team Leadership99Strategy99
+12 more
BiopharmaceuticalsRegulatory AffairsLife SciencesProduct LaunchClinical TrialsManagementFDAMarket AnalysisGMPMarket AccessNew Business DevelopmentFinancial AnalysisFrom Maziar's professional profile.
Frequently asked questions
- Who is Maziar Mike Doustdar?
- Maziar Mike Doustdar is President and CEO of Novo Nordisk, a company focused on the treatment and prevention of serious chronic diseases, including obesity, overweight, and diabetes. In this role, he oversees the company's work on reducing the incidence of metabolic and cardiovascular diseases, supporting earlier diagnosis, and providing patient treatment.
- Where did Maziar Mike Doustdar go to school?
- Maziar Mike Doustdar studied at Harvard Business School (Executive Education, Leadership in Pharmaceutical & Biotech); Webster Vienna Private University (B.A., Marketing); Primary school.
Same school
Also attended Harvard Business School2,000
Aileen LeeFounder & Managing Partner of Cowboy VenturesJim BreyerFounder & CEO of Breyer CapitalMike Maples JrCo-founding Partner at FloodgateNeeraj AgrawalGeneral Partner at Battery VenturesHristo BorisovCo-founder & CEO of PayhawkVictoria TreygerGeneral Partner at Felicis Ventures
+ 1,994 more
Also attended Webster Vienna Private University6
Daniele ProvenzanoHead of Transactions at PAMERA Real Estate Partners GmbHGregor JarischCTO & Head of Product at GnowbeChristoph FleischmannFounder at ArthurBola SokunbiFounder at Clever Girl FinanceChristian PangratzCEO & Board Director at Orikines’s WebsiteMirnas BrescicCEO & Founder at SaturnX Dubai, UAE Exited Acquired
Shared employers
Also worked at Novo Nordisk70
Jesper GromadaInvestor at Third Rock VenturesKevin GroveVenture Partner at Versant VenturesEmilia CarlqvistAnalyst, Innovestor Life Science at Innovestor VenturesBrian DanielsVenture Partner at 5AM VenturesKasim KutayCEO at Novo HoldingsTaruho KurodaImpact Partner at Fresco Capital
+ 64 more
